Quality Bone Densitometry: Performance, Interpretation, and Clinical Application for Clinicians
The core elements of this course serve to increase the knowledge and competence of clinicians regarding bone densitometry and osteoporosis diagnosis, clinical evaluation, treatment and monitoring and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The first day sets the standard to perform quality DXA interpretation, while the second day focuses on the clinical assessment, prevention, treatment and management/monitoring of osteoporosis and the essential role that high-quality DXA plays in treatment decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.
Prerequisite videos are included in the registration fees. While these are not required, it is suggested that registrants complete them in preparation for the course. Access to that content will be made available to registrants through the ISCD Learning Center prior to the program.
** Course schedules and fees are specific to the event. View the listings by clicking the course below for specific details to the course you wish to take.
Target Audience
The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD Quality Bone Densitometry for Technologists Course.
Course Objectives
After attending the course, participants should be better prepared to:
- Describe appropriate clinical evaluation of patients at risk for fragility fracture.
- Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD.
- Recognize errors in DXA analysis and reporting.
- Explain new and emerging guidelines that provide evidence-based information regarding skeletal health.
- Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.
Day 1: DXA Interpretation for Clinicians – the Importance of Doing a Quality DXA Scan and Quality DXA Reporting
Prerequisites
- Video A – Overview of Osteoporosis
- Video B – Fundamentals of Bone Densitometry, Physics, Radiation Safety, and Quality Assurance
Lectures
- Principles of Quality DXA Scan Acquisition, Analysis and Interpretation
- How to Diagnose Osteoporosis
- How to Assess Fracture Risk
- How to Monitor BMD Change Over Time
- How to Interpret and Report DXA Scans
- Closing Q&A Session
Day 2: DXA and Patient Care for Clinicians – Using Quality DXAs in Patient Care
Prerequisite
- Video C – What US Healthcare Providers Need to Know about DXA for Patient Care
Lectures
- Can You Trust This DXA Report?
- Clinical Evaluation of Bone Health and Fracture Risk
- Clinical Management Part I:Non-pharmacologic therapy
- Pharmacologic Therapy for Osteoporosis
- Clinical Management Part II: Adverse Effects of Osteoporosis Medications, Combination Therapy and Drug Holidays
- Case Discussions
- Closing Q&A Session
Continuing Medical Education Credits
ISCD intends to offer this activity for AMA PRA Category 1 CreditsTM. For approved credit counts, please refer to our course catalog and select the upcoming course you’d like to register for.
Interested in offering this course Internationally?
If you are interested in offering this ISCD course internationally, please submit an Interest Form.
